Contributions of Psychology to Research, Treatment, and Care of Pregnant Women With Opioid Use Disorder

被引:10
|
作者
Preis, Heidi [1 ]
Inman, Elizabeth M. [1 ]
Lobel, Marci [1 ]
机构
[1] SUNY Stony Brook, Dept Psychol, 100 Nicolls Rd, Stony Brook, NY 11794 USA
关键词
medication assisted treatment; opioid use disorder; pregnant women; reproductive health psychology; MOTIVATIONAL ENHANCEMENT THERAPY; MEDICATION-ASSISTED TREATMENT; NEONATAL ABSTINENCE SYNDROME; MATERNAL-FETAL-MEDICINE; ILLICIT-DRUG-USE; SUBSTANCE USE; UNITED-STATES; POSTPARTUM WOMEN; BUPRENORPHINE TREATMENT; TREATMENT SERVICES;
D O I
10.1037/amp0000675
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
The number of women with opioid use disorder (OUD) in the United States has risen precipitously. Pregnant women with OUD are a particularly vulnerable subset of addicted women with unique characteristics and needs. Many of them are impoverished, have strenuous life circumstances, are affected by past and current trauma, and have high rates of psychiatric comorbidities. Their addiction can compromise their and their infant's health, particularly without sufficient treatment including prenatal care, medication-assisted treatment (MAT), and social and behavioral care. Furthermore, these women's needs are often undetected and untreated: They may not seek appropriate prenatal and addiction care, or if they do, may face barriers to comprehensive, evidence-based treatment. Theories, methods, tools, and existing knowledge from the field of psychology are needed to improve research, prevention, and treatment for pregnant women with OUD. Although a number of psychologists have made critical contributions to research on pregnant women with OUD, we demonstrate by a scoping review of scientific literature and by examining American Psychological Association (APA) Annual Convention proceedings that much research on this population has been communicated in areas and journals outside psychology and among audiences other than psychologists. We identify relevant theoretical frameworks and methods to facilitate psychological investigation as well as evidence-based intervention and care for this population. Our field is well positioned to examine, identify, and alleviate the needs of pregnant women with OUD to improve their health and the health of their children.
引用
收藏
页码:853 / 865
页数:13
相关论文
共 50 条
  • [31] Is Weaning of Buprenorphine Safe for Pregnant Women with Opioid Use Disorder?
    Ramirez, Andrea
    Shah, Darshan
    PEDIATRICS, 2022, 149 (01)
  • [32] Cigarette Smoking Reduction in Pregnant Women With Opioid Use Disorder
    Ram, Anita
    Tuten, Michelle
    Chisolm, Margaret S.
    JOURNAL OF ADDICTION MEDICINE, 2016, 10 (01) : 53 - 59
  • [33] Women-centered drug treatment models for pregnant women with opioid use disorder: A scoping review
    Joshi, Chandni
    Skeer, Margie R.
    Chui, Kenneth
    Neupane, Gagan
    Koirala, Reecha
    Stopka, Thomas J.
    DRUG AND ALCOHOL DEPENDENCE, 2021, 226
  • [34] Initial Management of Incarcerated Pregnant Women With Opioid Use Disorder
    O'Connor, Alane
    Bowling, Nathaniel
    JOURNAL OF CORRECTIONAL HEALTH CARE, 2020, 26 (01) : 17 - 26
  • [35] Treating Tobacco Use Disorder in Pregnant Women in Medication-Assisted Treatment for an Opioid Use Disorder: A Systematic Review
    Akerman, Sarah C.
    Brunette, Mary F.
    Green, Alan I.
    Goodman, Daisy J.
    Blunt, Heather B.
    Heil, Sarah H.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2015, 52 : 40 - 47
  • [36] Association of methadone dose with substance use and treatment retention in pregnant and postpartum women with opioid use disorder
    Wilder, Christine M.
    Hosta, Daniel
    Winhusen, Theresa
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2017, 80 : 33 - 36
  • [37] When treating pregnant women with opioid use disorder, the benefits of using opioid maintenance treatment outweigh the risks
    Adis Medical Writers
    Drugs & Therapy Perspectives, 2016, 32 (5) : 186 - 190
  • [38] The Impact of Early Substance Use Disorder Treatment Response on Treatment Outcomes Among Pregnant Women With Primary Opioid Use
    Tuten, Michelle
    Fitzsimons, Heather
    Hochheimer, Martin
    Jones, Hendree E.
    Chisolm, Margaret S.
    JOURNAL OF ADDICTION MEDICINE, 2018, 12 (04) : 300 - 307
  • [39] Naltrexone Treatment for Pregnant Women With Opioid Use Disorder Compared With Matched Buprenorphine Control Subjects
    Wachman, Elisha M.
    Saia, Kelley
    Miller, Melissa
    Valle, Eduardo
    Shrestha, Hira
    Carter, Ginny
    Werler, Martha
    Jones, Hendree
    CLINICAL THERAPEUTICS, 2019, 41 (09) : 1681 - 1689
  • [40] Treatment of opioid use disorder in primary care
    Buresh, Megan
    Stern, Robert
    Rastegar, Darius
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 373